Home Cart 0 Sign in  
X

[ CAS No. 618-49-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 618-49-5
Chemical Structure| 618-49-5
Chemical Structure| 618-49-5
Structure of 618-49-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 618-49-5 ]

Related Doc. of [ 618-49-5 ]

Alternatived Products of [ 618-49-5 ]

Product Details of [ 618-49-5 ]

CAS No. :618-49-5 MDL No. :MFCD00017572
Formula : C7H7NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :NGMMGKYJUWYIIG-UHFFFAOYSA-N
M.W : 137.14 Pubchem ID :342403
Synonyms :

Calculated chemistry of [ 618-49-5 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 36.56
TPSA : 63.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.86 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.8
Log Po/w (XLOGP3) : 0.39
Log Po/w (WLOGP) : 0.49
Log Po/w (MLOGP) : 0.58
Log Po/w (SILICOS-IT) : 0.5
Consensus Log Po/w : 0.55

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.31
Solubility : 6.66 mg/ml ; 0.0485 mol/l
Class : Very soluble
Log S (Ali) : -1.29
Solubility : 7.1 mg/ml ; 0.0518 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.38
Solubility : 5.69 mg/ml ; 0.0415 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 618-49-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 618-49-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 618-49-5 ]
  • Downstream synthetic route of [ 618-49-5 ]

[ 618-49-5 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 100-83-4 ]
  • [ 618-49-5 ]
YieldReaction ConditionsOperation in experiment
50% With hydroxylamine hydrochloride; caesium carbonate In water; dimethyl sulfoxide at 125℃; for 48 h; General procedure: Aldehyde (0.5mmol), NH2OH·HCl (0.6mmol) and Cs2CO3 (0.6mmol) were stirred at 125°C for 48h in a 3:1 mixture of DMSO–H2O (2mL) under air. The progress of the reaction was monitored by TLC using ethyl acetate and hexane as eluent. After completion, the reaction mixture was cooled to room temperature and treated with water (1mL). The resulting mixture was extracted with ethyl acetate (3×5mL). Drying (Na2SO4) and evaporation of the solvent gave a residue that was purified on silica gel column chromatography using ethyl acetate and hexane. The purified products were identified by 1H NMR spectra and the melting points comparison with the literature data.
Reference: [1] Tetrahedron, 2002, vol. 58, # 52, p. 10323 - 10328
[2] RSC Advances, 2014, vol. 4, # 27, p. 13782 - 13787
[3] RSC Advances, 2016, vol. 6, # 43, p. 37093 - 37098
[4] Synthesis, 2002, # 8, p. 1057 - 1060
[5] Journal of Chemical Research - Part S, 2003, # 3, p. 176 - 178
[6] European Journal of Organic Chemistry, 2014, vol. 2014, # 34, p. 7590 - 7593
[7] Tetrahedron Letters, 2014, vol. 55, # 20, p. 3192 - 3194
[8] Applied Organometallic Chemistry, 2018, vol. 32, # 6,
  • 2
  • [ 873-62-1 ]
  • [ 618-49-5 ]
YieldReaction ConditionsOperation in experiment
54%
Stage #1: at 50℃; for 70 h;
Stage #2: With hydrogenchloride In methanol; water
Example 49; 3-Hydroxybenzamide (49a). 3-Cyanophenol (295 mg, 2.48 mmol, 100 mol-percent) and NaBO3 - 4 H2O (1146 mg, 7.45 mmol, 300 mol-percent) in H2O (8 ml_) were heated to 50 0C and MeOH (14 ml_) was added until mixture was clear. The mixture was stirred at 50 0C for 70 hours and excess MeOH was evaporated and the pH of remaining mixture was adjusted to 5 with cone. HCI (aq). Mixture was extracted with CH2CI2 (12 ml_) and with EtOAc (5x15 ml_). Organic phases were combined, washed with brine (25 ml_) and dried over Na2SO4. Filtering and evaporation of solvents gave 49a as spectro- scopically pure white solid (183 mg, 54percent): mp 165-168 0C; Rf (50percent EtOAc in hex) 0.10.
Reference: [1] RSC Advances, 2015, vol. 5, # 16, p. 12152 - 12160
[2] Tetrahedron, 1989, vol. 45, # 11, p. 3299 - 3306
[3] ChemMedChem, 2010, vol. 5, # 2, p. 213 - 231
[4] Patent: WO2008/129129, 2008, A1, . Location in patent: Page/Page column 66
  • 3
  • [ 40812-76-8 ]
  • [ 618-49-5 ]
YieldReaction ConditionsOperation in experiment
7.03 g With ammonium hydroxide In tetrahydrofuran at 20℃; Cooling with ice To a solution of 3-hydroxybenzoic acid (1) (10.0 g, 72.41 mmol) in toluene (80 mL) at room temperature was slowly added thionyl chloride (7.71 mL, 108.62 mmol). The resulting solution was heated to reflux for 4.5 h and concentrated in vacuo to give crudeproduct of 3-hydroxybenzoyl chloride (2). The crude product was dissolved in THF (30 mL) in an ice-methanol bath and concentrated aqueous ammonia (28 mL) was dropwise added.The resulting reaction mixture was warmed slowly to room temperature and stirredfor 18 h at the same temperature. After concentrating in vacuo, the residue was suspended in water (20 mL) and filtered. The collected solid was washed with water (3 × 15 mL) and then dried in vacuo to give 3-hydroxybenzamide (3) (7.03g, 70.8percent) as anoff-white crystals. mp 160–163 °C, TLC Rf= 0.12 (petroleum ether/ethyl acetate, 1:2); IR (KBr): 2958, 2925, 2851, 1113, 638, 615 cm-1;1H NMR (600 MHz, DMSO-d6, FontSize="10" δppm): 9.60 (s, 1H), 7.86 (s,1H), 7.29–7.21 (m, 4H), 6.90 (dd, J =7.8 Hz, J = 1.8 Hz, 1H); MS(ESI) m/z calcd for C7H7NO2 137.0; found (M + H+) 138.3.
7.03 g With ammonia In tetrahydrofuran; water at 20℃; for 18 h; Cooling with ice To a solution of 3-hydroxybenzoic acid (1) (5.0 g, 36.21mmol) in toluene (40 mL) at room temperature was slowly added thionyl chloride (3.86 mL, 54.38 mmol). The reaction solution was heated to reflux for 4.5 h and concentrated invacuo to give 3-hydroxybenzoyl chloride (2). The crude product 2 was dissolved in THF (15 mL) in an ice bath and aqueous ammonia (14 mL) was dropwise added. The resulting mixture was slowly warmed to room temperature and stirred for 18 h at the same temperature. After concentrating in vacuo, the residue was suspended in water (10 mL) and filtered. The collected solid was washed with water (3 x10mL) and then dried in vacuo to give 3-hydroxybenzamide (3)(7.03 g, 70.8percent) as an off-white solid. mp 160–163°C, TLC Rf = 0.12 (petroleum ether/ethyl acetate, 1:2); IR (KBr):2958, 2925, 2851, 1113, 638, 615 cm-1; 1H NMR (600 MHz,DMSO-d6, ppm) 9.60 (s, 1H), 7.86 (s, 1H), 7.29–7.21 (m,4H), 6.90 (dd, J = 7.8 Hz, J = 1.8 Hz, 1H); MS (ESI) m/z calcd for C7H7NO2 137.0; found [M+H]+ 138.3; Analysis calculated for C7H7NO2: C 61.31, H 5.14, N 10.21; Found: C61.42, H 5.12, N 10.22.
Reference: [1] Justus Liebigs Annalen der Chemie, 1925, vol. 442, p. 41
[2] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 2, p. 524 - 527
[3] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 14, p. 4076 - 4079
[4] Letters in Drug Design and Discovery, 2013, vol. 10, # 4, p. 320 - 326
[5] Chemical Biology and Drug Design, 2016, vol. 87, # 2, p. 257 - 264
[6] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 7, p. 667 - 672
[7] Patent: WO2007/107758, 2007, A1, . Location in patent: Page/Page column 21
  • 4
  • [ 19438-10-9 ]
  • [ 618-49-5 ]
YieldReaction ConditionsOperation in experiment
10% With ammonia In methanol at 50℃; for 16 h; Sealed tube . Example 25 Synthesis of 3-hydroxybenzamideTo a reactor was charged methyl 3-hydroxybenzoate (160 mg) and 7N ammonia in methanol (4 ml). The reactor was then sealed, heated to 50 °C, and stirred for 16 hours. The reaction mixture was cooled to ambient temperature then reduced by rotary evaporation to yield an oil. This was purified by flashchromatography, eluting with n-hexane and ethyl acetate. Appropriate fractions were collected for the product peak and were reduced by rotary evaporation to obtain the desired product as yellow oil (15 mg, 10percent). The structure was confirmed as 3-hydroxybenzamide by 1H NMR.
Reference: [1] Patent: WO2016/114668, 2016, A1, . Location in patent: Page/Page column 37
[2] Biochemical Journal, 1948, vol. 43, p. 561,562
  • 5
  • [ 55-21-0 ]
  • [ 618-49-5 ]
  • [ 619-57-8 ]
  • [ 18543-22-1 ]
  • [ 65-45-2 ]
YieldReaction ConditionsOperation in experiment
35% With (difluoroboryl)dimethylglyoximatocobalt(II) bis(acetonitrile); water; 3-cyano-1-methylquinolinium cation In acetonitrile at 20℃; for 5 h; Inert atmosphere; Irradiation; Green chemistry Using 1-methyl-3-cyanoquinoline salt as photosensitizer, cobalt oxime complex 2 as cobalt catalyst and 5mL of acetonitrile, 2.69mg (1 × 10-2mmol) photosensitizer and 2.80mg ) Cobalt catalyst, the atmosphere was replaced with Ar atmosphere, Then 0.2 mmol of benzamide (R1 is CONH2, R2, R3, R4 are independently H) and 2 mmol H2O. Room temperature, high pressure mercury lamp irradiation 5h. After completion of the reaction, H2 production was detected by GC (TCD), benzene conversion by GC (FID) was detected, and then column separation was performed. Nuclear magnetic hydrogenSpectroscopy and mass spectrometry identified products as 2-hydroxybenzamide, 3-hydroxybenzamide,4-hydroxybenzamide and Ν- (3-carbamoylphenyl) benzamide. The conversion of benzamide was 63percent, the yields of 2-hydroxybenzamide, 3-hydroxybenzamide and 4-hydroxybenzamide were 35percent, 8percent, 11percentThe yield of N- (2-carbamoylphenyl) benzamide was 9percent and the yield of H2 was 58percent.
Reference: [1] Patent: CN107324975, 2017, A, . Location in patent: Paragraph 0118-0119
[2] Journal of the American Chemical Society, 2016, vol. 138, # 32, p. 10080 - 10083
  • 6
  • [ 99-06-9 ]
  • [ 618-49-5 ]
YieldReaction ConditionsOperation in experiment
64% With thionyl chloride; ammonia In tetrahydrofuran; benzene EXAMPLE 1
Preparation of 3-Hydroxybenzamide
Ten g (72.4 mmol) of 3-hydroxybenzoic acid and 10 ml SOCl2 were mixed and allowed to stand for 1 hr, heated on a steam bath for 2 hr, and then cooled and diluted with 25 ml of benzene.
The benzene was then evaporated in vacuo to dryness and the residue extracted with 2*50 ml benzene.
The extracted residue was dissolved in 25 ml tetrahydrofuran (THF) and this solution added dropwise over a period of 15 min to a stirred, cold (-10° C.) 50 ml solution of concentrated ammonia.
The mixture was stirred with cooling for an hour and then at room temperature overnight.
The mixture was poured into an open dish and allowed to evaporate to a solid mass.
The solid was triturated with 50 ml ice water, collected, and air dried to yield 6.4 g (64percent) of the desired product 3-hydroxybenzamide, mp 160°-162° C.
The identity of the product with the desired 3-hydroxybenzamide was further confirmed using thin layer chromatography (TLC).
Reference: [1] Journal of the Indian Chemical Society, 2005, vol. 82, # 7, p. 675 - 676
[2] Phosphorus and Sulfur and the Related Elements, 1980, vol. 9, p. 155 - 164
[3] Naunyn-Schmiedebergs Archiv fuer Experimentelle Pathologie und Pharmakologie, 1938, vol. 191, p. 55,57
[4] Patent: US5032617, 1991, A,
[5] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 14, p. 4076 - 4079
[6] Letters in Drug Design and Discovery, 2013, vol. 10, # 4, p. 320 - 326
[7] Chemical Biology and Drug Design, 2016, vol. 87, # 2, p. 257 - 264
[8] Angewandte Chemie - International Edition, 2017, vol. 56, # 46, p. 14498 - 14501[9] Angew. Chem., 2017, vol. 129, p. 14690 - 14693,4
[10] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 5, p. 884 - 891
[11] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 7, p. 667 - 672
[12] Patent: WO2007/107758, 2007, A1,
  • 7
  • [ 171861-74-8 ]
  • [ 618-49-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 5, p. 884 - 891
  • 8
  • [ 6304-89-8 ]
  • [ 618-49-5 ]
Reference: [1] Chimica Therapeutica, 1967, vol. 2, p. 57 - 65
[2] Patent: US5756510, 1998, A,
  • 9
  • [ 620-24-6 ]
  • [ 618-49-5 ]
Reference: [1] Catalysis Communications, 2012, vol. 26, p. 48 - 53
  • 10
  • [ 22241-18-5 ]
  • [ 618-49-5 ]
Reference: [1] Applied Organometallic Chemistry, 2018, vol. 32, # 6,
  • 11
  • [ 5813-86-5 ]
  • [ 618-49-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 2, p. 524 - 527
  • 12
  • [ 7781-98-8 ]
  • [ 618-49-5 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1880, vol. <2> 22, p. 290
[2] Naunyn-Schmiedebergs Archiv fuer Experimentelle Pathologie und Pharmakologie, 1938, vol. 191, p. 55,57
  • 13
  • [ 100-83-4 ]
  • [ 618-49-5 ]
  • [ 873-62-1 ]
Reference: [1] Synthesis, 2003, # 2, p. 243 - 246
  • 14
  • [ 69026-14-8 ]
  • [ 618-49-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 5, p. 884 - 891
  • 15
  • [ 61535-46-4 ]
  • [ 618-49-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 5, p. 884 - 891
  • 16
  • [ 16446-73-4 ]
  • [ 618-49-5 ]
Reference: [1] Chimica Therapeutica, 1967, vol. 2, p. 57 - 65
  • 17
  • [ 618-49-5 ]
  • [ 873-62-1 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 7, p. 667 - 672
  • 18
  • [ 100-83-4 ]
  • [ 618-49-5 ]
  • [ 873-62-1 ]
Reference: [1] Synthesis, 2003, # 2, p. 243 - 246
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 618-49-5 ]

Aryls

Chemical Structure| 65-45-2

[ 65-45-2 ]

2-Hydroxybenzamide

Similarity: 0.93

Chemical Structure| 3424-93-9

[ 3424-93-9 ]

4-Methoxybenzamide

Similarity: 0.91

Chemical Structure| 40187-51-7

[ 40187-51-7 ]

5-Acetyl-2-hydroxybenzamide

Similarity: 0.84

Chemical Structure| 936-02-7

[ 936-02-7 ]

2-Hydroxybenzohydrazide

Similarity: 0.84

Chemical Structure| 2439-77-2

[ 2439-77-2 ]

2-Methoxybenzamide

Similarity: 0.84

Amides

Chemical Structure| 65-45-2

[ 65-45-2 ]

2-Hydroxybenzamide

Similarity: 0.93

Chemical Structure| 3424-93-9

[ 3424-93-9 ]

4-Methoxybenzamide

Similarity: 0.91

Chemical Structure| 40187-51-7

[ 40187-51-7 ]

5-Acetyl-2-hydroxybenzamide

Similarity: 0.84

Chemical Structure| 252061-66-8

[ 252061-66-8 ]

5-Hydroxyisoindolin-1-one

Similarity: 0.84

Chemical Structure| 936-02-7

[ 936-02-7 ]

2-Hydroxybenzohydrazide

Similarity: 0.84

Amines

Chemical Structure| 65-45-2

[ 65-45-2 ]

2-Hydroxybenzamide

Similarity: 0.93

Chemical Structure| 3424-93-9

[ 3424-93-9 ]

4-Methoxybenzamide

Similarity: 0.91

Chemical Structure| 40187-51-7

[ 40187-51-7 ]

5-Acetyl-2-hydroxybenzamide

Similarity: 0.84

Chemical Structure| 936-02-7

[ 936-02-7 ]

2-Hydroxybenzohydrazide

Similarity: 0.84

Chemical Structure| 2439-77-2

[ 2439-77-2 ]

2-Methoxybenzamide

Similarity: 0.84